发明名称 |
Recombinant fusion proteins |
摘要 |
This invention provides a DNA sequence coding for a cleavage site which is specifically cleaved by blood coagulation Factor Xa, a vector containing such a sequence, and a host organism transformed with such a vector. Preferably, in the vector, the Factor Xa cleavage site coding sequence is fused at one end to a product and at its other end to an ATG codon or a sequence coding for at least part of a host protein. This invention also provides a process, for the production of a desired protein or peptide product in native form, comprising: transforming a host organism with a vector as described above; expressing the desired protein or peptide product as a fusion protein comprising the desired protein or peptide product fused to a Factor Xa cleavage site; and a cleaving the fusion protein with Factor Xa to yield the foreign gene product in native form.
|
申请公布号 |
US6010883(A) |
申请公布日期 |
2000.01.04 |
申请号 |
US19920854749 |
申请日期 |
1992.03.19 |
申请人 |
CELLTECH THERAPEUTICS LIMITED |
发明人 |
NAGAI, KIYOSHI;THOEGERSEN, HANS CHRISTIAN |
分类号 |
C12N15/09;A61K35/74;A61K38/00;C07H21/04;C07K1/22;C07K14/00;C07K14/195;C07K14/41;C07K14/47;C07K14/575;C07K14/585;C07K14/805;C07K19/00;C12N1/20;C12N1/21;C12N9/00;C12N9/10;C12N15/00;C12N15/62;C12P21/00;C12P21/02;C12R1/125;C12R1/19;(IPC1-7):C12N15/62;C12N15/74;C12N15/12;C12N15/13;C12N15/14 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|